SARAH TALBOTT: Open Payments
NPI 1447816863 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 17 payments from 4 companies in 2025. Trend: 2023 $316 · 2024 $340 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $143 |
| Boston Scientific Corporation | 1 | $113 |
| Madrigal Pharmaceuticals | 1 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: ENTYVIO, EXALT Model D, REZDIFFRA, XIFAXAN.
Industry payments across MI — which companies pay providers there.
